SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-013943
Filing Date
2005-03-31
Accepted
2005-03-30 22:02:18
Documents
14
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a05-5589_110k.htm 10-K 2037486
2 EX-10.5 a05-5589_1ex10d5.htm EX-10.5 228091
3 EX-10.18 a05-5589_1ex10d18.htm EX-10.18 143784
4 EX-10.20 a05-5589_1ex10d20.htm EX-10.20 776553
5 EX-10.21 a05-5589_1ex10d21.htm EX-10.21 420641
6 EX-10.22 a05-5589_1ex10d22.htm EX-10.22 263277
7 EX-10.23 a05-5589_1ex10d23.htm EX-10.23 352958
8 EX-21.1 a05-5589_1ex21d1.htm EX-21.1 1324
9 EX-23.1 a05-5589_1ex23d1.htm EX-23.1 1733
10 EX-23.2 a05-5589_1ex23d2.htm EX-23.2 3798
11 EX-31.1 a05-5589_1ex31d1.htm EX-31.1 9528
12 EX-31.2 a05-5589_1ex31d2.htm EX-31.2 9355
13 EX-32.1 a05-5589_1ex32d1.htm EX-32.1 6817
14 EX-32.2 a05-5589_1ex32d2.htm EX-32.2 5159
  Complete submission text file 0001104659-05-013943.txt   4263596
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 05716213
SIC: 2834 Pharmaceutical Preparations